Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
In the latest session, Cg Oncology Inc (NASDAQ: CGON) closed at $35.50 up 1.00% from its previous closing price of $35.15. In other words, the price has increased by $1.00 from its previous closing price. On the day, 0.7 million shares were traded. CGON stock price reached its highest trading level at $36.05 during the session, while it also had its lowest trading level at $34.8.
Ratios:
For a deeper understanding of Cg Oncology Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 35.32 and its Current Ratio is at 35.32. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, UBS on October 24, 2024, initiated with a Buy rating and assigned the stock a target price of $60.
On September 23, 2024, RBC Capital Mkts started tracking the stock assigning a Outperform rating and target price of $66.
On August 28, 2024, ROTH MKM started tracking the stock assigning a Buy rating and target price of $65.ROTH MKM initiated its Buy rating on August 28, 2024, with a $65 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Aug 29 ’24 when Song Hong Fang sold 650,455 shares for $35.36 per share. The transaction valued at 23,000,089 led to the insider holds 586,982 shares of the business.
Unique Diamond Investments Ltd bought 424,210 shares of CGON for $15,000,000 on Aug 29 ’24. On Aug 29 ’24, another insider, Charming Jade Ltd, who serves as the Director of the company, bought 226,245 shares for $35.36 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CGON now has a Market Capitalization of 2400854272 and an Enterprise Value of 1860439424. For the stock, the TTM Price-to-Sale (P/S) ratio is 3530.66 while its Price-to-Book (P/B) ratio in mrq is 4.47. Its current Enterprise Value per Revenue stands at 2719.941 whereas that against EBITDA is -19.393.
Stock Price History:
Over the past 52 weeks, CGON has reached a high of $50.23, while it has fallen to a 52-week low of $25.77. The 50-Day Moving Average of the stock is -3.54%, while the 200-Day Moving Average is calculated to be -2.62%.
Shares Statistics:
For the past three months, CGON has traded an average of 641.43K shares per day and 415720 over the past ten days. A total of 66.64M shares are outstanding, with a floating share count of 40.23M. Insiders hold about 40.02% of the company’s shares, while institutions hold 56.65% stake in the company. Shares short for CGON as of 1730332800 were 5598991 with a Short Ratio of 8.73, compared to 1727654400 on 6972378. Therefore, it implies a Short% of Shares Outstanding of 5598991 and a Short% of Float of 8.430000399999999.
